Results for
"[search-keyword]"
Sponsor content
310 result(s) found, displaying 21 to 30
-
Designation or determinationProvisional determination
-
-
May-2024Prescription medicine evaluationActive ingredient: datopotamab deruxtecan.
-
May-2024Prescription medicine evaluationActive ingredient: datopotamab deruxtecan.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Prescription medicine registrationActive ingredients: sodium zirconium cyclosilicate hydrate.
-
Apr-2024Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.5 mg/ml nebuliser suspension.